ArticleRespiratory research2025

Thioredoxin: a key factor in cold tumor formation and a promising biomarker for immunotherapy resistance in NSCLC.

Jiayi Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.